| Structure |
Chemical Name |
CAS |
MF |
 |
NS-2028 (SGC inhibitor) |
|
|
|
|
CYT997 (LEXIBULIN) (MICROTUBULES inhibitor) |
|
|
|
|
Chemiluminescent reagents |
|
|
|
|
ACP-196 (BTK inhibitor) |
|
|
|
|
0.9% saline |
|
|
|
|
DALCETRAPIB (CETP inhibitor) |
|
|
|
|
NU-7441 (DNA-PK inhibitor) |
|
|
 |
Solifenacin |
242478-37-1 |
C23H26N2O2 |
|
|
DL2000 DNA Marker |
|
|
|
|
Mounting Medium, antifading |
|
|
|
|
MONOMETHYL AURISTATIN E (microtubule-associated inhibitor) |
|
|
![3-Azetidinecarboxamide, 1-(aminosulfonyl)-N-(6-chloro-4-methoxy-3-pyridinyl)-3-[2-(1-methylethyl)phenyl]-](/CAS/20210305/GIF/2569467-78-1.gif) |
3-Azetidinecarboxamide, 1-(aminosulfonyl)-N-(6-chloro-4-methoxy-3-pyridinyl)-3-[2-(1-methylethyl)phenyl]- |
2569467-78-1 |
C19H23ClN4O4S |
 |
Porfiromycin |
801-52-5 |
C16H20N4O5 |
 |
4-DIMETHYLAMINO-7-(4-ETHYL-PHENYL)-7H-9-THIA-1,5,7-TRIAZA-FLUOREN-8-ONE |
869802-44-8 |
C19H18N4OS |
|
|
Antibody dilution |
|
|
|
|
Saponification fluid |
|
|
 |
Sparstolonin B |
1259330-61-4 |
C15H8O5 |
|
|
AC-YVAD-PNA (CASPASE 1 chromogenic substrate) |
|
|
|
|
Protein protectant TY |
|
|
 |
GW 876008X |
786701-13-1 |
C22H24N6O2 |
|
|
SRT 2104 (SIRT1 activator) |
|
|
|
|
SNX-2112 (PF-04928473) (HSP90 antimony inhibitor) |
|
|
|
|
TAE (50X) |
|
|
|
|
S2RA (SIGMA RECEPTOR antagonist) |
|
|
|
|
AZD4547 (FGFR inhibitor) |
|
|
![N-[4-Methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)-1,1-biphenyl-4-carboxamide hydrate hydrochloride](//CAS/GIF/148642-42-6.gif) |
N-[4-Methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)-1,1-biphenyl-4-carboxamide hydrate hydrochloride |
148642-42-6 |
C29H31N5O3·HCl |
|
|
GSK1292263 (GPR agonist) |
|
|
|
|
BCIP/NBT alkaline phosphatase substrate solution |
|
|
|
|
TBA-354 (anti-tuberculosis) |
|
|
|
|
TETRABENAZINE (VMAT-2 Inhibitor) |
|
|
|
|
ENDOFECTIN LENTI Transfection Reagent |
|
|
|
|
OSELTAMIVIR ACID (NEURAMINIDASE Inhibitor) |
|
|
 |
FENOBAM |
57653-26-6 |
C11H11ClN4O2 |
 |
Eliapixant |
1948229-21-7 |
C22H21F3N4O3S |
|
|
Penicillin-Streptomycin for Cell Culture |
|
|
|
|
LCZ696 (RAAS inhibitor) |
|
|
|
|
CH5183284 (FGFR inhibitor) |
|
|
 |
H-GLU-ILE-GLY-ASP-GLU-GLU-ASN-SER-ALA-LYS-PHE-PRO-ILE-NH2 |
125934-45-4 |
C63H98N16O23 |
 |
BDA-366 |
1909226-00-1 |
C24H29N3O4 |
|
|
TWS119 (GSK-3 inhibitor) |
|
|
|
|
CAL-101 (PI3K inhibitor) |
|
|
|
|
NECROSTATIN-1 (TNF-ALPHA inhibitor) |
|
|
 |
Quininib |
143816-42-6 |
C17H13NO |
 |
Tedalinab |
916591-01-0 |
C19H21F2N3O |
|
|
ENDOFECTIN HEPG2 Transfection Reagent |
|
|
|
|
BD FACS Clean Solution |
|
|
 |
Radiprodil |
496054-87-6 |
C21H20FN3O4 |
|
|
Myocardial biochemical test kit |
|
|
![Pyrido[4,3-d]pyrimidin-4(1H)-one (9CI)](/CAS/GIF/16952-64-0.gif) |
Pyrido[4,3-d]pyrimidin-4(1H)-one (9CI) |
16952-64-0 |
C7H5N3O |
|
|
EVEROLIMUS (MTOR inhibitor) |
|
|
|
|
GSK2141795 (AKT inhibitor) |
|
|
|
|
BYL719 (PI3K inhibitor) |
|
|
 |
TUFTSIN |
9063-57-4 |
C21H40N8O6 |
|
|
SB203580 (P38 MAPK Inhibitor) |
|
|
|
|
Precipitate TMB solutions |
|
|
|
|
AVASIMIBE (P450 inhibitor) |
|
|
|
|
Rapid Blocking Buer (TBS-T) |
|
|
 |
Budiodarone tartrate |
1346623-17-3 |
C33H35F4N3O2 |
|
|
B-27 serum-free additive, 50X, no vitamin A |
|
|
|
|
CABOZANTINIB (VEGFR inhibitor) |
|
|
 |
1-Methylpyrrolidin-3-ol |
13220-33-2 |
C5H11NO |
|
|
AZILSARTAN (RAAS antagonist) |
|
|
![1-[2-(3,4-Dichlorophenyl)ethyl]-4-Methylpiperazine Dihydrochloride](/CAS/GIF/206996-13-6.gif) |
1-[2-(3,4-Dichlorophenyl)ethyl]-4-Methylpiperazine Dihydrochloride |
206996-13-6 |
C13H19Cl3N2 |
|
|
ML324 (HISTONE DEMETHYLASE inhibitor) |
|
|
|
|
DAPIVIRINE (REVERSE TRANSCRIPTASE Inhibitor) |
|
|
|
|
Ampicillin (100mg/ml,1000X) |
|
|
|
|
GZD824 DIMESYLATE (BCR-ABL inhibitor) |
|
|
|
|
BI2536 (PLK inhibitor) |
|
|
 |
(D-ALA7)-ANGIOTENSIN I/II (1-7) |
159432-28-7 |
C39H60N12O11 |
|
|
SEMAGACESTAT (GAMMA - SECRETASE Inhibitor) |
|
|
|
|
ENTOSPLETINIB (SYK inhibitor) |
|
|
|
|
TEDIZOLID (MAO-A inhibitor) |
|
|
|
|
ABT-199 (BCL-2 inhibitor) |
|
|
|
|
BOUIN'S SOLUTION |
|
|
|
|
SANT-1 (HEDGEHOG/SMOOTHENED antagonist) |
|
|
|
|
TG101348 (JAK inhibitor) |
|
|
|
|
PFI-4 (EPIGENETIC READER DOMAIN inhibitor) |
|
|
|
|
Protein Marker |
|
|
|
|
GSH (antioxidant) |
|
|
|
|
AR-A014418 (GSK-3 inhibitor) |
|
|
 |
Exatecan mesylate |
169869-90-3 |
C25H26FN3O7S |
 |
BMS813160 |
1286279-29-5 |
C25H40N8O2 |
|
|
MLN9708 (20S PROTEASOME Inhibitor) |
|
|
|
|
HYDROXYUREA (DNA SYNTHESIS inhibitor) |
|
|
|
|
WESTERN Antibody Eluent (Strongly Basic) |
|
|
 |
PSD506 |
754177-77-0 |
C22H37N3O3S |
|
|
DACLATASVIR (HCV NS5A inhibitor) |
|
|
|
|
KU0063794 (MTOR inhibitor) |
|
|
|
|
Spore Stain Kit |
|
|
|
|
TG101209 (JAK inhibitor) |
|
|
|
|
GANT61 (HEDGEHOG/SMOOTHENED Inhibitor) |
|
|
|
|
Gene transfection enhancer |
|
|
 |
5'-Guanylic acid, 3'-O-methyl- |
400806-41-9 |
C11H16N5O8P |
 |
Acetyl coenzyme A sodium salt |
102029-73-2 |
C23H38N7O17P3S.3Na |
![Ethanone, 1-[4-(4-chloro-3-methoxyphenyl)-1-piperazinyl]-2-[3-(1H-imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]-](/CAS/20180527/GIF/1010073-75-2.gif) |
Ethanone, 1-[4-(4-chloro-3-methoxyphenyl)-1-piperazinyl]-2-[3-(1H-imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]- |
1010073-75-2 |
C22H22ClN7O2 |
![Urea, N-[2-[2-(1,1-diMethylethyl)phenoxy]-3-pyridinyl]-N'-[4-(trifluoroMethoxy)phenyl]-](/CAS/20150408/GIF/870544-59-5.gif) |
Urea, N-[2-[2-(1,1-diMethylethyl)phenoxy]-3-pyridinyl]-N'-[4-(trifluoroMethoxy)phenyl]- |
870544-59-5 |
C23H22F3N3O3 |
|
|
TUBASTATIN A (HDAC inhibitor) |
|
|
|
|
Skimmed Milk Powder |
|
|
|
|
30% Acr-Bis (29:1) |
|
|
|
|
ZOTAROLIMUS (MTOR inhibitor) |
|
|